glp-1 in type 1 diabetes patients with residual ß-cell function, treatment Ozempic and Other Off-Label Drugs
Description
Backed by 3 powerful mechanisms: GLP-1 Core Act
86F/30C for others)
For most patients in clinical trials, GI side effects were described as mild-to-moderate and transient
Short-term prediction of glucose in type 1 diabetes using kernel adaptive filters
Two people taking the same medication can have very different experiences
Skibickas lab has found that women, on average, lose more weight than men on equivalent doses, possibly due to interactions between GLP-1 signaling and estrogen
